NCT02604433 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 224
- group Id
- BG001
- value
- 112
- group Id
- BG002
- value
- 336
- units
- Participants
- groups
- description
- Luspatercept (ACE-536) was administered subcutaneously (SC) at a starting dose level of 1 mg/kg once every 21 days. Participants could be dose-titrated to 1.25 mg/kg, but the maximum total dose should not exceed 120 mg, total dose per administration during the Treatment Period, the Long-term Treatment Period, and Open-Label Treatment Period. BSC = Best Supportive Care
- id
- BG000
- title
- Luspatercept + BSC
- description
- Placebo (normal saline) was administered subcutaneously (SC) in volumes to match active treatment once every 21 days. BSC = Best Supportive Care
- id
- BG001
- title
- Placebo + BSC
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.67
- value
- 32.2
- group Id
- BG001
- spread
- 9.89
- value
- 31.9
- group Id
- BG002
- spread
- 10.40
- value
- 32.1
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 132
- group Id
- BG001
- value
- 63
- group Id
- BG002
- value
- 195
- title
- Female
- measurements
- group Id
- BG000
- value
- 92
- group Id
- BG001
- value
- 49
- group Id
- BG002
- value
- 141
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 7
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 218
- group Id
- BG001
- value
- 107
- group Id
- BG002
- value
- 325
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 4
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 81
- group Id
- BG001
- value
- 36
- group Id
- BG002
- value
- 117
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 122
- group Id
- BG001
- value
- 60
- group Id
- BG002
- value
- 182
- title
- White
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 10
- title
- Not collected or reported
- measurements
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 11
- group Id
- BG002
- value
- 26
- title
- Other
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- population Description
- All randomized participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 224
- group Id
- BG001
- value
- 112
- group Id
- BG002
- value
- 336
- units
- Participants
- groups
- description
- Luspatercept (ACE-536) was administered subcutaneously (SC) at a starting dose level of 1 mg/kg once every 21 days. Participants could be dose-titrated to 1.25 mg/kg, but the maximum total dose should not exceed 120 mg, total dose per administration during the Treatment Period, the Long-term Treatment Period, and Open-Label Treatment Period. BSC = Best Supportive Care
- id
- BG000
- title
- Luspatercept + BSC
- description
- Placebo (normal saline) was administered subcutaneously (SC) in volumes to match active treatment once every 21 days. BSC = Best Supportive Care
- id
- BG001
- title
- Placebo + BSC
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.67
- value
- 32.2
- group Id
- BG001
- spread
- 9.89
- value
- 31.9
- group Id
- BG002
- spread
- 10.40
- value
- 32.1
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 132
- group Id
- BG001
- value
- 63
- group Id
- BG002
- value
- 195
- title
- Female
- measurements
- group Id
- BG000
- value
- 92
- group Id
- BG001
- value
- 49
- group Id
- BG002
- value
- 141
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 7
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 218
- group Id
- BG001
- value
- 107
- group Id
- BG002
- value
- 325
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 4
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 81
- group Id
- BG001
- value
- 36
- group Id
- BG002
- value
- 117
- title
- Asian
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 122
- group Id
- BG001
- value
- 60
- group Id
- BG002
- value
- 182
- title
- White
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 10
- title
- Not collected or reported
- measurements
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 11
- group Id
- BG002
- value
- 26
- title
- Other
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- population Description
- All randomized participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle